Patients with hereditary angioedema experience recurrent and sometimes life-threatening swelling attacks. Researchers from Charité – Universitätsmedizin Berlin have tested an antibody capable of reducing the frequency of these swelling attacks by more than 90 percent. Results from their phase 3 trial were published yesterday in JAMA, the renowned Journal of the American Medical Association. Hereditary […]Continue Reading ...
Terrorist attacks injure far more people than they kill, leaving victims with lost limbs, hearing loss, respiratory disease, depression and other issues. But little research has measured the impact of that damage beyond the number of people who are hurt. New research from The University of Texas at Dallas provides a more complete picture of […]Continue Reading ...
August 7, 2018 Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug-delivery system that allows rapid response to heart attacks without surgical intervention. In laboratory and animal testing, the system proved to be effective at dissolving clots, limiting long-term scarring to heart tissue and preserving […]Continue Reading ...
By Dr Ananya Mandal, MD,April 18, 2018 According to a pilot study results released yesterday (17th of April 2018), a new drug may help provide relief to people with migraine that is unsuccessfully treated with the currently available drugs. Researchers have developed Erenumab, which belongs to a human monoclonal antibody class of drugs that can […]Continue Reading ...
Among patients with cardiovascular disease, it’s a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular disease (CVD) appear to be intimately linked—they are frequently seen together although the underlying connection between the two […]Continue Reading ...
Dublin, Ireland – Thursday, June 21, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG), the leading global biotechnology company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for Cinryze (C1 esterase inhibitor [human]), making it available to help prevent angioedema attacks in children aged […]Continue Reading ...
Credit: University of Nottingham Serious asthma attacks in adults can be reduced by a temporary but significant increase in the dose of inhaled steroids during severe episodes of asthma, according to a new UK-wide study led by experts at the University of Nottingham. Previous research at the University has found that doubling the dose of […]Continue Reading ...
- Pre-injury exercise reduces damage to both muscles and nerves, study finds
- Minimizing Antibody Size to Maximize Research Potential
- Research finds large genome in tiny forest defoliator
- Technology helps reduce the yearning for unhealthy food
- New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
- What you should know about teeth whitening
- Why Older Adults Should Eat More Protein (And Not Overdo Protein Shakes)
- Colorectal cancer mortality rates predicted to increase globally
- Scientists discover mutational signatures of tumor hypoxia
- New evidence shows how fever alters immune cells
- Researchers find new class of blood pressure-regulating peptides in vampire bat venom
- Promega to exhibit new Maxwell RSC48 platform at 2019 Festival of Genomics
- Study pinpoints immune cells that could be key to tackling hypertension
- Couples Intervention May Aid Partners of Diabetes Patients
- Your weight history may predict your heart failure risk
- Explore a cornucopia of accomplishments in prematurity research
- New study identifies four characteristics that predict severity of postpartum depression
- New, scalpel-free treatment for reducing Parkinson’s tremor gets FDA approval
- Neurobiologists uncover key component of how the human brain marks time
- LifeTime receives fund to develop a plan to embed its vision for healthier future